Targeted Protein Degradation Platform
Targeted protein degradation (TPD) technology has become one of the most promising methods to remove specific disease-related proteins using cellular self-destruction mechanisms. This technology is enabling researchers to pursue targets that were previously considered undruggable and to address the resistance issue of small molecule inhibitors.
Since 2016, WuXi AppTec has built a comprehensive TPD discovery service platform to investigate the full functional cycle of protein degraders – from binary/ternary complex formation to target ubiquitination and degradation. At the 7th Annual TPD & Induced Proximity Summit, we presented a poster demonstrating the capabilities of our TPD platform, highlighting TPD research strategies through relevant case studies.

Poster_TPD and Induced Proximity Summit
Related Content
Strategies to stimulate dendritic cell (DC) activity, such as ex vivo generation and priming of DC vaccines, have been explored...
VIEW RESOURCEIntroduction: RNA-based therapies are a frontier in biomedicine, with the potential to fundamentally change treatments for a wide range of...
VIEW RESOURCE
